These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 8204923)

  • 1. [Hereditary predisposition for cancer of the breast and the ovary].
    Lalle P; Stoppa-Lyonnet D; Mazoyer S; Rio P; Girodet C; Hardouin A; Narod SA; Sobol H; Bignon YJ
    Bull Cancer; 1993 Oct; 80(10):857-65. PubMed ID: 8204923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q.
    Stratton MR; Ford D; Neuhasen S; Seal S; Wooster R; Friedman LS; King MC; Egilsson V; Devilee P; McManus R
    Nat Genet; 1994 May; 7(1):103-7. PubMed ID: 8075631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
    Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
    J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.
    Lynch HT; Watson P; Conway TA; Lynch JF; Slominski-Caster SM; Narod SA; Feunteun J; Lenoir G
    Arch Intern Med; 1993 Sep; 153(17):1979-87. PubMed ID: 8357282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkage analysis of DRD2, a marker linked to the ataxia-telangiectasia gene, in 64 families with premenopausal bilateral breast cancer.
    Cortessis V; Ingles S; Millikan R; Diep A; Gatti RA; Richardson L; Thompson WD; Paganini-Hill A; Sparkes RS; Haile RW
    Cancer Res; 1993 Nov; 53(21):5083-6. PubMed ID: 8221639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage analysis of 19 French breast cancer families, with five chromosome 17q markers.
    Mazoyer S; Lalle P; Narod SA; Bignon YJ; Courjal F; Jamot B; Dutrillaux B; Stoppa-Lyonnett D; Sobol H
    Am J Hum Genet; 1993 Apr; 52(4):754-60. PubMed ID: 8096359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.
    Saito H; Inazawa J; Saito S; Kasumi F; Koi S; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
    Cancer Res; 1993 Jul; 53(14):3382-5. PubMed ID: 8100738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial breast-ovarian cancer locus on chromosome 17q12-q23.
    Narod SA; Feunteun J; Lynch HT; Watson P; Conway T; Lynch J; Lenoir GM
    Lancet; 1991 Jul; 338(8759):82-3. PubMed ID: 1676470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
    Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
    Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22.
    Rahman N; Teare MD; Seal S; Renard H; Mangion J; Cour C; Thompson D; Shugart Y; Eccles D; Devilee P; Meijers H; Nathanson KL; Neuhausen SL; Weber B; Chang-Claude J; Easton DF; Goldgar D; Stratton MR
    Oncogene; 2000 Aug; 19(36):4170-3. PubMed ID: 10962578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of breast cancer pedigrees using affected sibship methods.
    Barrett JH; Rigby AS
    Genet Epidemiol; 1995; 12(6):847-51. PubMed ID: 8788020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial ovarian carcinoma: pedigree studies and preliminary results from linkage analysis.
    Sobol H; Mazoyer S; Smith SA; Lyonnet D; Bignon YJ; Narod SA; Ardoin A; Biron P; Bobin JY; Bremond A
    Bull Cancer; 1993 Feb; 80(2):121-34. PubMed ID: 8173163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation to determine whether clusters of cancer types exist in nine breast-ovary families.
    Bansal A; Bishop DT; Cannings C
    Genet Epidemiol; 1995; 12(6):841-6. PubMed ID: 8788019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 susceptibility markers and postmenopausal breast cancer: the Iowa Women's Health Study.
    Thompson JA; Chen PL; King RA; Rich SS; Oetting WS; Armstrong C; Folsom AR; Sellers TA
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):507-11. PubMed ID: 10815696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing.
    Foulkes WD; Narod SA
    Clin Invest Med; 1995 Dec; 18(6):473-83. PubMed ID: 8714791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families.
    Seitz S; Rohde K; Bender E; Nothnagel A; Kölble K; Schlag PM; Scherneck S
    Oncogene; 1997 Feb; 14(6):741-3. PubMed ID: 9038382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.
    Narod SA; Ford D; Devilee P; Barkardottir RB; Lynch HT; Smith SA; Ponder BA; Weber BL; Garber JE; Birch JM
    Am J Hum Genet; 1995 Jan; 56(1):254-64. PubMed ID: 7825586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer.
    Torchard D; Blanchet-Bardon C; Serova O; Langbein L; Narod S; Janin N; Goguel AF; Bernheim A; Franke WW; Lenoir GM
    Nat Genet; 1994 Jan; 6(1):106-10. PubMed ID: 7511021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.